{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:53:24Z","timestamp":1795038804795,"version":"4.10.2"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biomaterials.2025.123168","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T02:55:12Z","timestamp":1739328912000},"page":"123168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A novel FTO-targeting nanodrug induces disulfidptosis and ameliorates the suppressive tumor immune environment to treat uveal melanoma"],"prefix":"10.1016","volume":"319","author":[{"given":"Hao","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongpei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9311-0799","authenticated-orcid":false,"given":"Chuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam W.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-4568","authenticated-orcid":false,"given":"Jing","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2025.123168_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10555-018-9762-9","article-title":"Cancers of the eye","volume":"37","author":"Maheshwari","year":"2018","journal-title":"Cancer metastasis reviews"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","article-title":"Metastatic disease from uveal melanoma: treatment options and future prospects","volume":"101","author":"Carvajal","year":"2017","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123168_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/08820538.2016.1154175","article-title":"Tumor characteristics, genetics, management, and the risk of metastasis in uveal melanoma","volume":"31","author":"Nichols","year":"2016","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.biomaterials.2025.123168_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.preteyeres.2018.03.004","article-title":"Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - a personal view","volume":"66","author":"Damato","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123168_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00262-019-02352-6","article-title":"Pembrolizumab as first-line treatment for metastatic uveal melanoma","volume":"68","author":"Rossi","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"7229","key":"10.1016\/j.biomaterials.2025.123168_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"issue":"6009","key":"10.1016\/j.biomaterials.2025.123168_bib8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123168_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","article-title":"R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m(6)A\/PFKP\/LDHB axis","volume":"81","author":"Qing","year":"2021","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123168_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"7544","key":"10.1016\/j.biomaterials.2025.123168_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature14281","article-title":"N6-methyladenosine marks primary microRNAs for processing","volume":"519","author":"Alarc\u00f3n","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123168_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","article-title":"The roles and implications of RNA m6A modification in cancer","volume":"20","author":"Deng","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12943-020-01194-6","article-title":"Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation","volume":"19","author":"Shi","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-019-1088-x","article-title":"m(6)A modification suppresses ocular melanoma through modulating HINT2 mRNA translation","volume":"18","author":"Jia","year":"2019","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123168_bib15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123168_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cac2.12075","article-title":"The FTO\/miR-181b-3p\/ARL5B signaling pathway regulates cell migration and invasion in breast cancer","volume":"40","author":"Xu","year":"2020","journal-title":"Cancer Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123168_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ymthe.2022.10.012","article-title":"N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis","volume":"31","author":"Lin","year":"2023","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123168_bib19","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1002\/ctm2.310","article-title":"FTO modifies the m6A level of MALAT and promotes bladder cancer progression","volume":"11","author":"Tao","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib20","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","article-title":"m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123168_bib21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","article-title":"Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance","volume":"33","author":"Liu","year":"2021","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123168_bib22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1021\/ar200105p","article-title":"Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine","volume":"44","author":"Al-Jamal","year":"2011","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123168_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1775","article-title":"Design and development of polymers for gene delivery","volume":"4","author":"Pack","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2010.06.004","article-title":"Gold nanoparticle platforms as drug and biomacromolecule delivery systems","volume":"148","author":"Duncan","year":"2010","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123168_bib25","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/cbic.201800685","article-title":"Selective delivery of doxorubicin to EGFR(+) cancer cells by cetuximab-DNA conjugates","volume":"20","author":"Liu","year":"2019","journal-title":"Chembiochem"},{"issue":"40","key":"10.1016\/j.biomaterials.2025.123168_bib26","doi-asserted-by":"crossref","first-page":"14021","DOI":"10.1021\/jacs.7b08303","article-title":"A molecular recognition approach to synthesize nucleoside analogue based multifunctional nanoparticles for targeted cancer therapy","volume":"139","author":"Wang","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123168_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123168_bib28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"21","key":"10.1016\/j.biomaterials.2025.123168_bib29","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1021\/jacs.2c02277","article-title":"Chemical and biophysical signatures of the protein corona in nanomedicine","volume":"144","author":"Ren","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccell.2017.12.013","article-title":"Integrative analysis identifies Four molecular and clinical subsets in uveal melanoma","volume":"33","author":"Robertson","year":"2018","journal-title":"Cancer Cell"},{"issue":"37","key":"10.1016\/j.biomaterials.2025.123168_bib31","doi-asserted-by":"crossref","first-page":"59209","DOI":"10.18632\/oncotarget.10962","article-title":"Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas","volume":"7","author":"Field","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2025.123168_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.exer.2019.04.001","article-title":"Spatial intratumor heterogeneity in uveal melanoma: tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction","volume":"182","author":"Herwig-Carl","year":"2019","journal-title":"Exp. Eye Res."},{"issue":"43","key":"10.1016\/j.biomaterials.2025.123168_bib33","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/cac2.12471","article-title":"Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m(6) A RNA methylation in ocular melanoma","author":"Zhuang","year":"2023","journal-title":"Cancer Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123168_bib34","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41388-021-02146-0","article-title":"The m(6)A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation","volume":"41","author":"Xu","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol."},{"issue":"43","key":"10.1016\/j.biomaterials.2025.123168_bib36","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1021\/ja3064149","article-title":"Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor","volume":"134","author":"Chen","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123168_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2025.123168_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123168_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2025.123168_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.858462","article-title":"The role of cystine\/glutamate antiporter slc7a11\/xCT in the pathophysiology of cancer","volume":"12","author":"Jyotsana","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123168_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.857765","article-title":"FTO prevents thyroid cancer progression by SLC7A11 m6A methylation in a ferroptosis-dependent manner","volume":"13","author":"Ji","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biomaterials.2025.123168_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101801","article-title":"The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function","volume":"38","author":"Ma","year":"2021","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123168_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.778","article-title":"The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma","volume":"12","author":"Liu","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123168_bib45","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202255681","article-title":"FTO negatively regulates the cytotoxic activity of natural killer cells","volume":"24","author":"Kim","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biomaterials.2025.123168_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.biomaterials.2025.123168_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molliq.2012.10.013","article-title":"Determination of critical micelle concentration of polybutadiene-block-poly(ethyleneoxide) diblock copolymer by fluorescence spectroscopy and dynamic light scattering","volume":"177","author":"Topel","year":"2013","journal-title":"J. Mol. Liq."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225000870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225000870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T05:32:57Z","timestamp":1741584777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225000870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S0142961225000870"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123168","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel FTO-targeting nanodrug induces disulfidptosis and ameliorates the suppressive tumor immune environment to treat uveal melanoma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123168"}}